Website Notice Block

Press Releases

Date	Title and Summary	View
Toggle SummaryMay 12, 2014	MediWound Completes Recruitment of Commercial Management Team in Europe Expanding Commercial and R&D Leadership	View HTML MediWound Completes Recruitment of Commercial Management Team in Europe 19.9 KB
Toggle SummaryMay 8, 2014	MediWound Expands Distribution of NexoBrid to Russia Through Agreement With Genfa Medica	View HTML MediWound Expands Distribution of NexoBrid to Russia Through Agreement With Genfa Medica 15.9 KB
Toggle SummaryMay 5, 2014	MediWound Announces Extraordinary General Meeting of Shareholders	View HTML MediWound Announces Extraordinary General Meeting of Shareholders 15.9 KB
Toggle SummaryMay 2, 2014	MediWound Reports First Quarter 2014 Financial Results	View HTML MediWound Reports First Quarter 2014 Financial Results 35.4 KB
Toggle SummaryMarch 25, 2014	MediWound Announces Closing of Initial Public Offering	View HTML MediWound Announces Closing of Initial Public Offering 13.1 KB
Toggle SummaryMarch 20, 2014	MediWound Prices Initial Public Offering	View HTML MediWound Prices Initial Public Offering 11.5 KB
Toggle SummarySeptember 23, 2012	Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™ NexoBrid™ has shown statistically significant effect in earlier eschar removal from burn wounds and reduction in the number and extent of surgical excision and autografting	View HTML Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™ 13.9 KB